DoW Traumatic Brain Injury and Psychological Health, Health Services Research Award

The Traumatic Brain Injury and Psychological Health Research Program Health Services Research Award is administered by the Defense Health Agency through the Congressionally Directed Medical Research Programs. This funding opportunity is part of a broader federal effort to improve prevention, diagnosis, treatment, and rehabilitation of traumatic brain injury and psychological health conditions affecting service members, veterans, their families, and the general public. The program has a long-standing history, with billions of dollars appropriated since its inception, and is focused on advancing research that translates scientific discoveries into practical health care improvements. The purpose of this award mechanism is to support high-impact health services research that bridges the gap between research, clinical practice, and policy. The program emphasizes generating real-world evidence on how interventions, clinical practices, diagnostics, and policies can be effectively implemented in targeted populations. Projects must include clinical research or clinical trials involving human subjects, and must be hypothesis-driven. The funding specifically excludes basic, preclinical, and animal research, reinforcing its focus on applied, patient-centered outcomes and implementation science. Funding is structured to support a small number of large-scale projects. The program anticipates allocating approximately 8 million dollars to fund about two awards, with each award capped at 4 million dollars in total costs over a maximum performance period of four years. Applicants may request the full funding amount regardless of project duration within that limit. The funding can be used for a range of allowable costs including personnel, research activities, travel for dissemination, and community-based participatory research implementation. However, certain costs such as tuition and excessive travel are restricted. Cost sharing is not required, which lowers the barrier to participation for eligible organizations. Eligibility for this opportunity is broad and inclusive. Both domestic and international organizations may apply, including for-profit and nonprofit entities, academic institutions, and government organizations. Principal Investigators must be independent investigators affiliated with an eligible organization, and early-career investigators are encouraged through a partnering option that allows two principal investigators to collaborate on a project. Individuals in training roles such as postdoctoral fellows are not eligible to serve as principal investigators. Applications are limited in number per investigator to prevent over-submission. The application process is structured as a two-step submission. First, applicants must submit a pre-application in the form of a Letter of Intent through the Electronic Biomedical Research Application Portal. This is followed by a full application submission through either Grants.gov or eBRAP depending on the applicant type. The full application requires extensive documentation, including a project narrative, technical and lay abstracts, a statement of work, regulatory strategy, recruitment and safety plans, and multiple supporting attachments. Applications are evaluated through a two-tier review process consisting of peer review and programmatic review, with emphasis on impact, feasibility, and alignment with program priorities. Key evaluation criteria include the scientific merit of the research, the strength of the study design, the potential impact on clinical practice and patient outcomes, and the feasibility of implementation. Additional considerations include ethical standards, recruitment strategies, statistical rigor, and plans for data sharing and dissemination. Community-based participatory research approaches are required for studies involving prospective human subjects, ensuring that research is informed by and responsive to the needs of affected populations. The timeline for this funding opportunity includes a pre-application deadline in late September and a full application deadline in mid-October. Peer review is expected to occur in December, followed by programmatic review in March, with awards anticipated to be made by the end of the following fiscal year. Projects are expected to begin within a defined timeframe after award and adhere to strict reporting and regulatory requirements. This funding opportunity is offered annually as part of the broader research program, making it a recurring opportunity for organizations engaged in health services research.

Focus on real-world implementation and impact; ensure strong preliminary data; align with defined focus areas; include robust clinical trial design and community-based participatory research integration